 |
|
|
| |
Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naïve, HIV-1-infected patients in ECHO and THRIVE
|
| |
| |
Reported by Jules Levin
Glasgow 2010 Nov 7-11
Herta M Crauwels,1 Erno van Schaick,2 Rolf PG van Heeswijk,1 Simon Vanveggel,1 Katia Boven,3 Peter Vis1
1Tibotec BVBA, Beerse, Belgium; 2Exprimo NV, Mechelen, Belgium; 3Tibotec Inc., Titusville, NJ, USA
|
| |
|
|
|
|
|
